Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemochromatosis”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Not applicableStudy completedNCT04631718
What this trial is testing

MRI QSM Imaging for Iron Overload

Who this might be right for
HemochromatosisIron Overload
University of Wisconsin, Madison 63
Testing effectiveness (Phase 2)Study completedNCT00600938
What this trial is testing

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

Who this might be right for
Transfusional Iron OverloadTransfusional Hemosiderosis
Novartis Pharmaceuticals 197
Post-approval studies (Phase 4)Study completedNCT00481143
What this trial is testing

Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload

Who this might be right for
Myelodysplastic SyndromesTransfusion Dependent Iron Overload
Novartis Pharmaceuticals 63
Post-approval studies (Phase 4)Study completedNCT00171301
What this trial is testing

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

Who this might be right for
Beta-thalassemia MajorHemosiderosisIron Overload+1 more
Novartis Pharmaceuticals 233
Testing effectiveness (Phase 2)Ended earlyNCT03203850
What this trial is testing

Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)

Who this might be right for
Hereditary Hemochromatosis
Novartis Pharmaceuticals 45
Not applicableStudy completedNCT06336577
What this trial is testing

Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-France

Who this might be right for
Down Syndrome
Centre Hospitalier Sud Francilien 108
Not applicableStudy completedNCT01784939
What this trial is testing

HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis C282Y Homozygous
Rennes University Hospital 31
Not applicableStudy completedNCT00587535
What this trial is testing

Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration

Who this might be right for
Hemochromatosis
Mayo Clinic 18
Not applicableUnknownNCT05593068
What this trial is testing

Iron Deposits in the Pancreas by MRI Method of Dialysis Patients With Hemosiderosis Iatrogenic (ERDFP)

Who this might be right for
Iron DepositionDialysisIatrogenic Hemosiderosis
Ramsay Générale de Santé 185
Testing effectiveness (Phase 2)Study completedNCT04202965
What this trial is testing

PTG-300 in Subjects With Hereditary Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis
Protagonist Therapeutics, Inc. 16
Not applicableLooking for participantsNCT04779593
What this trial is testing

Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis

Who this might be right for
Haemochromatosis
Rennes University Hospital 240
Testing effectiveness (Phase 2)Ended earlyNCT02263638
What this trial is testing

Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study

Who this might be right for
Refractory Hemochromatosis Rheumatism
Rennes University Hospital 17
Testing effectiveness (Phase 2)Study completedNCT00303329
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

Who this might be right for
AnemiaHemosiderosis
Novartis Pharmaceuticals 184
Large-scale testing (Phase 3)Study completedNCT00061750
What this trial is testing

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Beta-Thalassemia
Novartis Pharmaceuticals 595
Not applicableStudy completedNCT00005541
What this trial is testing

Hemochromatosis and Iron Overload Screening Study (HEIRS)

Who this might be right for
Blood DiseaseHemochromatosisIron Overload
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT05742035
What this trial is testing

Quality and Biologic Characteristics of Red Blood Concentrates Obtained From Individuals With Elevated Ferritin.

Who this might be right for
Hereditary HemochromatosisHyperferritinemia
Interregionale Blutspende SRK 100
Testing effectiveness (Phase 2)Study completedNCT00067080
What this trial is testing

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Anemia, Sickle Cell
Novartis Pharmaceuticals 195
Large-scale testing (Phase 3)Ended earlyNCT00981370
What this trial is testing

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

Who this might be right for
Anemia, Sickle CellTransfusion Hemosiderosis
Children's Hospital Los Angeles 1
Large-scale testing (Phase 3)Study completedNCT00190385
What this trial is testing

Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis

Who this might be right for
Compensated Cirrhosis
Assistance Publique - Hôpitaux de Paris 1,200
Not applicableStudy completedNCT03066414
What this trial is testing

Respiratory Variations For Assessing Blood Withdrawal

Who this might be right for
Genetic Hemochromatosis
University Hospital, Lille 27
Load More Results